The characters shown are real patients and the required consent to use their stories has been obtained from the patients and families. Photographs are for illustrative purposes only.
Important advances in the treatment of SMA since 2007 include:1
Survival in infantile-onset (Type I) spinal muscular atrophy has improved substantially (p<0.001)2Survival of patients with SMA type 1 patients born in 1995-2006 (n = 78) was compared with that of patients born in 1980-1994 (n = 65) | ||
---|---|---|
Year of birth | Survival Probability after a year of birth | Median survival time (months) |
1980-1994 | 37% | 7.5 |
1995-2006 | 79% | 24 |
Adoption of comprehensive supportive care in infantile-onset (Type I) spinal muscular atrophy has increased.2,3 | ||
---|---|---|
SUPPORTIVE CARE | 1980-1994 (% of patients receiving) |
1995-2006 (% of patients receiving) |
Non-invasive positive pressure ventilation (NIPPV) | 31% | 82% |
Mechanical insufflation / exsufflation (MI-E) | 8% | 63% |
Supplementary feeding | 40% | 78% |
Adopting a proactive approach to care can influence the trajectory of disease progression and improve the natural history of SMA.1
SMA is a neuromuscular disease that requires multidisciplinary medical care, and in some instances, a palliative approach.1
An approach to intensively manage the symptoms of the disease. For children with SMA, a proactive approach may include earlier placement of a feeding tube, intensive respiratory support (e.g. non-invasive ventilation and cough assist machines), early spinal surgery and regular sessions of physical therapy.
An approach that aims to improve quality of life and relieve stress and discomfort. For children with SMA, the use of non-invasive ventilation may help avoid hospitalisation and the need for tracheostomy.
Musculoskeletal issues in SMA, such as scoliosis, may require bracing or surgery. Spinal curvature is a common concern, with scoliosis affecting 60-90% of children with SMA types 1 and 2 and initial presentation in early childhood.1
This may be addressed by surgical correction or positional support (e.g. bracing). The decision to perform surgical correction of complications such as scoliosis is based on the child’s spine curvature, pulmonary function, and bone maturity.1,6
INTERVENTIONS | POTENTIAL BENEFITS | CONSIDERATIONS |
---|---|---|
SURGERY |
|
|
BRACING |
|
|
Nutritional support and feeding are critical considerations in caring for a child with SMA.1,8,11
Children with SMA may have difficulty eating due to weak swallowing muscles and poor head control, putting them at risk of aspiration and poor nutrition. Feeding tubes may be an option for children when there is concern about growth failure, insufficient caloric intake or the safety of oral feeding.1,11
Common issues affecting nutrition in children with spinal muscular atrophy include:
ISSUE | DESCRIPTION | HOW IT CAN AFFECT PATIENT |
---|---|---|
ASPIRATION 1 |
|
|
NASOGASTRIC TUBE |
|
|
DYSPHAGIA (DIFFICULTY SWALLOWING) |
|
|
FEEDING PROBLEMS |
|
|
GORD (GASTRO-OESOPHAGEAL REFLUX DISEASE) |
|
|
OBESITY/OVERNUTRITION |
|
|
UNDER-NUTRITION |
|
|
INTERVENTIONS | POTENTIAL BENEFITS | CONSIDERATIONS |
---|---|---|
NASOJEJUNAL/ NASOGASTRIC TUBE |
|
|
GASTROSTOMY TUBE (G-tube) |
|
|
Respiratory compromise is the major cause of morbidity and mortality in SMA. These children may have decreased respiratory function, underdeveloped lungs, and difficulty coughing and clearing secretions.6,21
Respiratory compromise in children with infantile-onset (consistent with Type I) SMA may be differentiated into 3 categories:22
INTERVENTIONS | POTENTIAL BENEFITS | CONSIDERATIONS |
---|---|---|
NON-INVASIVE VENTILATION (NIV) |
|
|
COUGH ASSIST MACHINE (Insufflator-exsufflator) |
|
|
TRACHEOSTOMY (Invasive ventilatory support requiring long-term airway) |
|
|
While some children receive multidisciplinary care from physicians in their community, others go to neuromuscular disease centres specialising in SMA. While spinal muscular atrophy has a single genetic cause, its presentation, progression, and needs can vary widely.9,10
The characters shown are real patients and the required consent to use their stories has been obtained from the patients and families. Photographs are for illustrative purposes only. *Actor portrayal. The image used is a stock photo.
Neuromuscular disease centres specialising in SMA offer expert, coordinated multidisciplinary care, but may not be accessible or practical for all children.
A dedicated multidisciplinary care team is the emerging paradigm at these centers
At some centres, Centralised (shared) appointments allow families to see all necessary physicians on a single day at one facility
These centers provide care for the entire family, which may include genetic counselling and education
These centers may provide assistance (e.g parking, meals, lodging) for families traveling to the centre
The updated 2017 Consensus Statement for Standard of Care in Spinal Muscular Atrophy reflects new data and important advances in the management of SMA.1,21
The characters shown are real patients and the required consent to use their stories has been obtained from the patients and families. Photographs are for illustrative purposes only.
1. Mercuri E, et al. Diagnosis and management of spinal muscular atrophy: Part 1: Recommendations for diagnosis, rehabilitation, orthopedic and nutritional care. Neuromuscl Disord. 2018;28(2):103-115.
2. Oskoui M, Levy G, Garland CJ, et al. The changing natural history of spinal muscular atrophy type 1. Neurology 2007;69(20):1931-1936.
3. Chatwin M, Bush A, Simonds AK. Outcome of goal-directed non-invasive ventilation and mechanical insufflation/exsufflation in spinal muscular atrophy type I. Arch Dis Child 2011;96:426-432.
4. World Health Organization. WHO definition of palliative care. [online] [cited 2020 Oct 15]. Available from: URL: http://www.who.int/cancer/palliative/definition/en/.
5. The World Federation of Right to Die Societies. Comfort and palliative care. [online] [cited 2020 Oct 15]. Available from: URL: http://www.worldrtd.net/comfort-palliative-care.
6. Spinal Muscular Atrophy Clinical Research Center. Physical/occupational therapy. [online] 2013 Mar [cited 2020 Oct 15]. Available from: URL: http://columbiasma.org/pt-ot.html.
7. Mullender M, et al. A Dutch guideline for the treatment of scoliosis in neuromuscular disorders. Scoliosis 2008;3:14.
8. Tangsrud SE, Carlsen KC, Lund-Petersen I, Carlsen KH. Lung function measurements in young children with spinal muscular atrophy; a cross sectional survey on the effect of position and bracing. Arch Dis Child 2001;84(6):521-524.
9. Darras BT, Royden Jones H Jr, Ryan MM, De Vivo DC, eds. Neuromuscular Disorders of Infancy, Childhood, and Adolescence: A Clinician’s Approach. 2nd ed. London, UK: Elsevier; 2015.
10. Markowitz JA, Singh P, Darras BT. Spinal muscular atrophy: a clinical and research update. Pediatr Neurol 2012;46(1):1-12.
11. Cure SMA. Tube feeding and SMA: recommendations and practices. 2018 Annual SMA conference. [online] 2018 June [cited 2020 Oct 15]. Available from: URL: https://www.curesma.org/wp-content/uploads/2019/07/tube-feeding-conf-2018.pdf.
12. Birnkrant DJ, et al. Treatment of type I spinal muscular atrophy with noninvasive ventilation and gastrostomy feeding. Ped Neurol 1998;18(5):407-410.
13. Iannaccone ST. Modern management of spinal muscular atrophy. J Child Neurol 2007;22(8):974-978.
14. Nutrition basics: fostering health and growth for spinal muscular atrophy. [online] [cited 2020 Oct 15]. Available from: URL: http://curesma.ca/wp-content/uploads/2017/04/fsmac_nutrition2013-1.pdf.
15. Messina S, et al. Feeding problems and malnutrition in spinal muscular atrophy type II. Neuromuscul Disord 2008;18(5):389-393.
16. Cha TH, Oh DW, Shim JH. Noninvasive treatment strategy for swallowing problems related to prolonged nonoral feeding in spinal muscular atrophy. Dysphagia 2010;25(3):261-264.
17. Yang JH, Kasat NS, Suh SW, Kim SY. Improvement in reflux gastroesophagitis in a patient with spinal muscular atrophy after surgical correction of kyphoscoliosis. Clin Orthop Relat Res 2011;469(12):3501-3505.
18. Sproule DM, et al. Adiposity is increased among high-functioning, non-ambulatory patients with spinal muscular atrophy. Neuromuscul Disord 2010;20:448-452.
19. Sproule DM, et al. Increased fat mass and high incidence of overweight despite low body mass index in patients with spinal muscular atrophy. Neuromuscul Disord 2009;19(6):391-396.
20. Bladen CL, et al. Mapping the differences in care for 5,000 spinal muscular atrophy patients, a survey of 24 national registries in North America, Australasia and Europe. J Neurol 2014;261(1):152-163.
21. Finkel RS, et al. Diagnosis and management of spinal muscular atrophy: Part 2: Pulmonary and acute care; medications, supplements and immunizations; other organ systems; and ethics. Neuromuscul Disord 2018;28(3):197-207.
22. Bach JR. The use of mechanical ventilation is appropriate in children with genetically proven spinal muscular atrophy. Paediatr Resp Rev 2008;9(1):45-50.
23. Schroth MK. Breathing basics: respiratory care for children with spinal muscular atrophy [patient booklet]. [online] [cited 2020 Oct 15]. Available from: URL: https://www.curesma.org/wp-content/uploads/2019/07/breathing-basics.pdf.